# Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)

> **NCT05152966** · NA · COMPLETED · sponsor: **Boston Scientific Corporation** · enrollment: 20 (actual)

## Conditions studied

- Persistent Atrial Fibrillation

## Interventions

- **DEVICE:** Ablation

## Key facts

- **NCT ID:** NCT05152966
- **Lead sponsor:** Boston Scientific Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-09-16
- **Primary completion:** 2022-12-01
- **Final completion:** 2022-12-01
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2024-02-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05152966

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05152966, "Feasibility Study of the FARAPULSE™ Cardiac Ablation System Plus in the Treatment of Persistent Atrial Fibrillation(PersAFOne II)". Retrieved via AI Analytics 2026-06-05 from https://api.ai-analytics.org/clinical/NCT05152966. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*